Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Hypersensitivity × Breast × Clear all

Phase

Status

Sponsor Class

OTHER 8 OTHER_GOV 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1 NET 1 Gynecologic 1 Endocrine 1 Breast 1

Conditions

Breast Neoplasms 264 Triple Negative Breast Neoplasms 18 Neoplasms 9 Lymphedema 9 Motor Activity 8 Breast Cancer Lymphedema 8 Breast Cancer Female 8 Pathologic Complete Response 6 Neoplasm Metastasis 6 Colorectal Neoplasms 6 Colonic Neoplasms 6 Pain 5 Fatigue 5 Stomach Neoplasms 4 Pain, Postoperative 4 Recurrence 3 Radiodermatitis 3 Hereditary Breast and Ovarian Cancer Syndrome 3 Endometrial Neoplasms 3 Drug-Related Side Effects and Adverse Reactions 3 Treatment Adherence and Compliance 2 Thyroid Neoplasms 2 Seroma 2 Radiation Injuries 2 Ovarian Neoplasms 2 Melanoma 2 Lymphoma 2 Lung Neoplasms 2 Head and Neck Neoplasms 2 HER2-positive Breast Cancer 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02835625 2024-08-28

TOBE

Norwegian Institute of Public Health

Phase NA Completed

29,453 enrolled 15 charts

Breast Neoplasms, Hypersensitivity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡